BioCentury | Jul 19, 2010
Clinical News

Artiss regulatory update

...application of hemostatic drug or biological products using air- or gas-pressurized sprayers. Products affected include Artiss...
...Johnson. Baxter International Inc. (NYSE:BAX), Deerfield, Ill. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Product: Artiss...
BioCentury | Mar 24, 2008
Clinical News

Artiss regulatory update

...FDA approved Baxter's Artiss slow-setting fibrin sealant for use in adhering autologous skin grafts in adult...
...fibrin sealant for use in adhering autologous skin grafts in adult and pediatric burn patients. Artiss...
...to launch the product in late April/early May. Baxter International Inc. (NYSE:BAX), Deerfield, Ill. Product: Artiss...
BioCentury | Mar 24, 2008
Clinical News

Artiss: Phase III data

...In a Phase III trial in 138 burn patients requiring wound excision and skin grafting, Artiss...
...by planimetry and investigator assessments. Using the former measure, wound closure rates were 70.3% for Artiss...
...With the investigator assessments, the rates were 43.3% and 37% for Artiss and staples, respectively. Artiss...
Items per page:
1 - 3 of 3